These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30843756)

  • 1. Axonal damage in spinal cord is associated with gray matter atrophy in sensorimotor cortex in experimental autoimmune encephalomyelitis.
    Meyer CE; Gao JL; Cheng JY; Oberoi MR; Johnsonbaugh H; Lepore S; Kurth F; Thurston MJ; Itoh N; Patel KR; Voskuhl RR; MacKenzie-Graham A
    Mult Scler; 2020 Mar; 26(3):294-303. PubMed ID: 30843756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bringing CLARITY to gray matter atrophy.
    Spence RD; Kurth F; Itoh N; Mongerson CR; Wailes SH; Peng MS; MacKenzie-Graham AJ
    Neuroimage; 2014 Nov; 101():625-32. PubMed ID: 25038439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion Kurtosis Imaging maps neural damage in the EAE model of multiple sclerosis.
    Chuhutin A; Hansen B; Wlodarczyk A; Owens T; Shemesh N; Jespersen SN
    Neuroimage; 2020 Mar; 208():116406. PubMed ID: 31830588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estriol-mediated neuroprotection in multiple sclerosis localized by voxel-based morphometry.
    MacKenzie-Graham A; Brook J; Kurth F; Itoh Y; Meyer C; Montag MJ; Wang HJ; Elashoff R; Voskuhl RR
    Brain Behav; 2018 Sep; 8(9):e01086. PubMed ID: 30144306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous anti-CD20 antibody treatment delays gray matter atrophy in human myelin oligodendrocyte glycoprotein-induced EAE mice.
    Pol S; Liang S; Schweser F; Dhanraj R; Schubart A; Preda M; Sveinsson M; Ramasamy DP; Dwyer MG; Weckbecker G; Zivadinov R
    Exp Neurol; 2021 Jan; 335():113488. PubMed ID: 32991933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric magnetic resonance imaging for detection of pathological changes in the central nervous system of a mouse model of multiple sclerosis in vivo.
    Althobity AA; Khan N; Sandrock CJ; Woodruff TM; Cowin GJ; Brereton IM; Kurniawan ND
    NMR Biomed; 2023 Oct; 36(10):e4964. PubMed ID: 37122101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voxel-Based quantitative MRI reveals spatial patterns of grey matter alteration in multiple sclerosis.
    Lommers E; Guillemin C; Reuter G; Fouarge E; Delrue G; Collette F; Degueldre C; Balteau E; Maquet P; Phillips C
    Hum Brain Mapp; 2021 Mar; 42(4):1003-1012. PubMed ID: 33155763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis.
    Xiang B; Wen J; Cross AH; Yablonskiy DA
    J Magn Reson Imaging; 2019 Feb; 49(2):487-498. PubMed ID: 30155934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal cord gray matter atrophy correlates with multiple sclerosis disability.
    Schlaeger R; Papinutto N; Panara V; Bevan C; Lobach IV; Bucci M; Caverzasi E; Gelfand JM; Green AJ; Jordan KM; Stern WA; von Büdingen HC; Waubant E; Zhu AH; Goodin DS; Cree BA; Hauser SL; Henry RG
    Ann Neurol; 2014 Oct; 76(4):568-80. PubMed ID: 25087920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis.
    MacKenzie-Graham A; Kurth F; Itoh Y; Wang HJ; Montag MJ; Elashoff R; Voskuhl RR
    JAMA Neurol; 2016 Aug; 73(8):944-53. PubMed ID: 27294295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system targeted autoimmunity causes regional atrophy: a 9.4T MRI study of the EAE mouse model of Multiple Sclerosis.
    Hamilton AM; Forkert ND; Yang R; Wu Y; Rogers JA; Yong VW; Dunn JF
    Sci Rep; 2019 Jun; 9(1):8488. PubMed ID: 31186441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Magnetic Resonance Imaging of Rats with Experimental Autoimmune Encephalomyelitis Reveals Brain Cortex Remodeling.
    Tambalo S; Peruzzotti-Jametti L; Rigolio R; Fiorini S; Bontempi P; Mallucci G; Balzarotti B; Marmiroli P; Sbarbati A; Cavaletti G; Pluchino S; Marzola P
    J Neurosci; 2015 Jul; 35(27):10088-100. PubMed ID: 26157006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gray matter atrophy cannot be fully explained by white matter damage in patients with MS.
    Zhang J; Giorgio A; Vinciguerra C; Stromillo ML; Battaglini M; Mortilla M; Tappa Brocci R; Portaccio E; Amato MP; De Stefano N
    Mult Scler; 2021 Jan; 27(1):39-51. PubMed ID: 31976807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.
    Steenwijk MD; Daams M; Pouwels PJ; J Balk L; Tewarie PK; Geurts JJ; Barkhof F; Vrenken H
    Hum Brain Mapp; 2015 May; 36(5):1796-807. PubMed ID: 25627545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis.
    Ruggieri S; Petracca M; Miller A; Krieger S; Ghassemi R; Bencosme Y; Riley C; Howard J; Lublin F; Inglese M
    JAMA Neurol; 2015 Dec; 72(12):1466-74. PubMed ID: 26457955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in spinal cord stiffness in the course of experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
    Pyka-Fościak G; Zemła J; Lis GJ; Litwin JA; Lekka M
    Arch Biochem Biophys; 2020 Feb; 680():108221. PubMed ID: 31816310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
    Nocentini U; Bozzali M; Spanò B; Cercignani M; Serra L; Basile B; Mannu R; Caltagirone C; De Luca J
    Brain Imaging Behav; 2014 Sep; 8(3):378-86. PubMed ID: 22584774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis.
    MacKenzie-Graham AJ; Rinek GA; Avedisian A; Morales LB; Umeda E; Boulat B; Jacobs RE; Toga AW; Voskuhl RR
    J Neurosci Res; 2012 Jul; 90(7):1310-23. PubMed ID: 22411609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis.
    Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira A; Sastre-Garriga J; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Filippi M;
    Neurology; 2021 Mar; 96(11):e1561-e1573. PubMed ID: 33441452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysfunctional RNA-binding protein biology and neurodegeneration in experimental autoimmune encephalomyelitis in female mice.
    Salapa HE; Libner CD; Levin MC
    J Neurosci Res; 2020 Apr; 98(4):704-717. PubMed ID: 31755578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.